Tertiary Nav - Press Releases Press ReleasesMedia Statements Press Releases Items Per Page 102550 News Category Business & FinancialCitizenshipEarningsMedia StatementProduct NewsRecognitionRegulatoryScience & Innovation Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Date Title 7/14/09 AVI BioPharma, Inc. Presents at American Society of Virology Annual Meeting 6/26/09 AVI BioPharma Joining Russell 3000 Index 6/21/09 AVI BioPharma Under Contract with U.S. Defense Threat Reduction Agency for Development of Therapeutics Targeting H1N1 Swine Flu 6/10/09 AVI BioPharma, Inc. to Present at 7th Annual Biodefense Vaccines & Therapeutics Conference in Washington D.C. 6/4/09 AVI BioPharma Signs an Additional Drug Development Contract with Charley's Fund Inc. for Duchenne Muscular Dystrophy 5/19/09 AVI BioPharma, Inc. to Present at TIDES 2009 Conference 5/18/09 AVI BioPharma, Inc. Appoints Paul Medeiros as Chief Business Officer 5/11/09 AVI BioPharma Announces First Quarter 2009 Financial Results 5/6/09 AVI BioPharma Announces Department of Defense Funding to Accelerate Development of AVI-4658 for Duchenne Muscular Dystrophy 5/4/09 AVI BioPharma Announces First Quarter 2009 Financial Results Conference Call Pagination First page « first Previous page ‹ previous … Page 64 Page 65 Page 66 Page 67 Current page 68 Page 69 Page 70 Page 71 Page 72 … Next page next › Last page last » Displaying 671 - 680 of 812 Toolkit Print Page | Email Alerts | RSS Feeds | Contacts
Press Releases Items Per Page 102550 News Category Business & FinancialCitizenshipEarningsMedia StatementProduct NewsRecognitionRegulatoryScience & Innovation Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Date Title 7/14/09 AVI BioPharma, Inc. Presents at American Society of Virology Annual Meeting 6/26/09 AVI BioPharma Joining Russell 3000 Index 6/21/09 AVI BioPharma Under Contract with U.S. Defense Threat Reduction Agency for Development of Therapeutics Targeting H1N1 Swine Flu 6/10/09 AVI BioPharma, Inc. to Present at 7th Annual Biodefense Vaccines & Therapeutics Conference in Washington D.C. 6/4/09 AVI BioPharma Signs an Additional Drug Development Contract with Charley's Fund Inc. for Duchenne Muscular Dystrophy 5/19/09 AVI BioPharma, Inc. to Present at TIDES 2009 Conference 5/18/09 AVI BioPharma, Inc. Appoints Paul Medeiros as Chief Business Officer 5/11/09 AVI BioPharma Announces First Quarter 2009 Financial Results 5/6/09 AVI BioPharma Announces Department of Defense Funding to Accelerate Development of AVI-4658 for Duchenne Muscular Dystrophy 5/4/09 AVI BioPharma Announces First Quarter 2009 Financial Results Conference Call Pagination First page « first Previous page ‹ previous … Page 64 Page 65 Page 66 Page 67 Current page 68 Page 69 Page 70 Page 71 Page 72 … Next page next › Last page last » Displaying 671 - 680 of 812